the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..: "fremanezumab for the preventive treatment of chronic migraine.".. the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes..
. http://ndaviesco.com/?Pinogrand=170